Polycruz

Polycruz

TBA
2,306 Views
Polycruz, an esteemed blockchain and crypto-based company, operates with the prime objective of making the investors reap remarkable returns at low risk and minimal effort. CRUZ, the indigenous token of the platform, is a BEP-20 standard token built on the robust Binance Smart Chain network. It is one of the more successful network that assures swift transactions at an affordable price. It offers a decentralized NFT marketplace that permits the users to purchase, sell, trade, mint and stake NFTs effortlessly. CRUZ is designed to be a new-age crypto token that assists audiences all across the globe to get the comprehensive benefits of decentralization. Sovereignty, scalability and adaptability are the three essential parameters that the token concentrates on. Our platform works to bestow users with an out-of-the-world NFT trading experience. The marketplace is comprehensively packed with branded and rare NFTs. These NFTs are splendid assets that add colossal value to your collections. The rarer the asset, the more the profits will be. The NFTs can be anything - artworks, pictures, videos, music, memes, accessories, in-game assets, digital collectibles and much more. Moreover, the CRUZ token can by itself be a lucrative asset. The user will be entitled to exciting rewards on staking the CRUZ tokens. With a plan to commence a decentralized atmosphere in the near future, we will provide a seamless experience of exchanging, staking and earning revenue or rewards without any complication. Our platform aids the users with a fascinating and sustainable rate of return for staking the assets.
4.1
TOTAL SCORE
3.8
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Dates: TBA
Token info
Ticker: CRUZ
Platform: Binance Chain
Q1 2021
<br /> Polycruz<br /> r&d collection <br /> 1 trillion <br /> Cruz Token<br /> Development<br /> In Mainnet<br /> with burning<br /> Mechanism<br /> Polycruz <br /> Website Development
Q2 2022
<br /> Marketing<br /> nft marketplace <br /> development <br /> Airdrop <br /> Cruz Token<br /> Private sale<br /> Auditing<br /> Listing CRUZ tokens in<br /> exchange<br /> Public sale
Q3 2022
Launch<br /> nft marketplace <br /> creator <br /> onboard<br /> Multichain<br /> Multichain<br /> Integration compati<br /> bility<br /> Development <br /> NFT Game<br /> Assets<br /> Development
Q4 2022
<br /> Launch of<br /> NFT Game<br /> assets on <br /> marketplace<br /> seamless<br /> connection<br /> Listing CRUZ<br /> In Top <br /> Exchanges<br /> Integration of cross-chain compatibility
Mitesh
Founder | CEO
Participates in a number of projects
Praful
Chief Financial Officer
Participates in a number of projects
Viren
Chief Technology Officer
Participates in a number of projects

Advisors (2)

Michael
Advisor Founder of DTC
Participates in a number of projects
Pauras
Advisor Client Manager
Participates in a number of projects
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Xsure
Xsure is a decentralized risk management platform that facilitates real-time communication between insurance providers and the end customer. With the help of machine learning and blockchain trust-less governance technologies we have managed to eliminate third parties from the whole insurance life-cycle and turn it into a dynamic process instead of a static one.
Upcoming
Candao
"People can, DAO's do. Candao mission is to create a platform where individuals with the same business and social goals can come together to inspire, engage and build values together. Candao unlock people’s superpowers and let them tokenize the value they create, liquefy assets, connect existing ones, bring people together in order to build joint ventures, distribute profits between all involved people and unlock the value of everyone who plays different roles in everyday life."
Upcoming
Aimedis
Aimedis is an AI backed, blockchain and smart contract supported medical ecosystem, that changes the way patients, doctors, and hospitals communicate, connect and handle information. Using the Aimedis platform, users can store, secure and share their medical information only with the people they want to share it with by using the Aimedis right management system. Beside the records, AImedis offers videochat and communication with other patients and doctors, online prescriptions, online appointments, learning content, the inclusion of fitness trackers and devices like ECG or bloodpressure monitors into the system, while all transactions inside the system are backed by our porprietary private AIMChain blockchain, while the token is bound to a public blockchain (Aimedis dual-blockchain model). AIMSocial will be the new incentivised and decentralized medical social network where patients can help other patients and get rewarded for it, while the system is supported by AI.
Upcoming
Constellation
The Constellation protocol implements a horizontally scalable blockchain architecture known as Extended Trust Chain with a peer to peer layer known as a gossip protocol that can be deployed on a mobile device. Constellation approaches smart contracts with a microservice architecture allowing for highly available services to be chained and composed into distributed applications with just an understanding of each microservice’s SLA (service level agreement) and/or type signature. This architecture ensures high transaction throughput, allowing for consumer grade distributed applications to be built on Constellation.
Upcoming
AGATE
Agate is the world's most comprehensive decentralized blockchain platform for instant payment without volatility risk to mainstream crypto adoption.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.